咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Surrogate Role of CD85k on Mon... 收藏

Surrogate Role of CD85k on Monocytic Lineage Involved Leukemogenesis Biology and Clinical Aspect

Surrogate Role of CD85k on Monocytic Lineage Involved Leukemogenesis Biology and Clinical Aspect

作     者:Hasnaa A. Abo-Elwafa Shereen P. Aziz Heba A. Ahmed Elsayed Mostafa Ali Doaa S. Elsaied 

作者机构:Clinical Pathology Department Sohag Faculty of Medicine Sohag University Sohag Egypt Clinical Oncology Department Sohag Faculty of Medicine Sohag University Sohag Egypt 

出 版 物:《Open Journal of Blood Diseases》 (血液病期刊(英文))

年 卷 期:2018年第8卷第4期

页      面:61-73页

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:CD85k Monocytic Lineage Leukemia 

摘      要:Background: Unique receptor involved in leukemogenesis is CD85k;an immuneglobulin receptor for immune tolerance, CD36 is glycoprotein mediates cellular adhesion and metastatic spread, CD14, CD15 considered common monocytic markers. Aims: to investigate CD85k with monocytic lineage involved leukemia (MLIL) markers in leukemia pathogenesis and clinical presentation. Patients and Methods: 47 patients (32 diagnosed acute myeloid leukemia (AML);15 non-malignant hematological disease as a control), were included, aged from 2 to 80 years, all subjected to peripheral blood (***) and bone marrow (B.M) examination, immunophenotyping (IPT) using FASC Canto four color flow cytometer (FCM) Becton Dickenson (BD) USA, for CD13, CD33, MPO, HLA-DR, CD34, CD38, CD117, CD14, CD15 and CD36 the Mo Abs supplied by B.D Bioscience, and anti CD85k Mo Abs by Aveda de Coimbra Flamenco, reference No. 1399990130. Results: Frequency of CD85k is 19/32 (59.37%) of AML;14/14 (M4/M5) 100% positive CD85k, insignificant correlations of CD85k to sex, lymphadenopathy or organomegaly, platelets count and *** blast (P 0.05), significant to age 50,000 × 109/l, Hb 0.05). Conclusion: Although CD85k is MLIL associated marker, it is not correlated with other MLIL markers with frequency 100% in MLIL and 59.37% in AML, age predisposition is 35 years with no sex variation, significant correlation to progenitor and myeloid markers, it’s a crucial role in leukemogenesis biology, not in clinical presentations, considered good follow up predictor MLIL marker.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分